Deutsche Bank’s Vor Biopharma VOR Stock Holding History

Deutsche Bank’s Portfolio VOR Stock Details VOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$661K	Sell	34,665 -5,686	-14%	-$121K	﹤0.01%	2475
2026 Q2	$743K	Buy	+40,351	New	+$611K	﹤0.01%	2548
2024 Q2	–	Sell	-1,592	Closed	-$75.4K	–	3706
2024 Q1	$75.4K	Hold	1,592	–	–	﹤0.01%	3272
2023 Q4	$71.6K	Buy	+1,592	New	+$65.7K	﹤0.01%	3352
2022 Q2	–	Sell	-531	Closed	-$64K	–	4339
2022 Q1	$64K	Sell	531 -61	-10%	-$10.4K	﹤0.01%	3757
2021 Q4	$138K	Buy	592 +30	+5%	+$8.65K	﹤0.01%	3557
2021 Q3	$176K	Buy	562 +198	+54%	+$58.9K	﹤0.01%	3632
2021 Q2	$136K	Sell	364 -11	-3%	-$5.43K	﹤0.01%	4001
2021 Q1	$324K	Buy	+375	New	+$317K	﹤0.01%	3371

Other funds holding VOR

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Nan Fung Trinity Central, Hong Kong, Hong Kong $1.04B AUM 32.17% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return

Johnson & Johnson New Brunswick, New Jersey $762M AUM 69.66% 1-Year Est. Return

STRS Ohio Columbus, Ohio $27.1B AUM 34.64% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return

Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return

Deutsche Bank's VOR Position: Q3 2026 in Review

Deutsche Bank reduced its Vor Biopharma (VOR) stake by 14% in Q3 2026, selling an estimated $121K and leaving 34,665 shares worth $661K. The position accounts for ﹤0.01% of the portfolio, ranked #2475.

Deutsche Bank first reported a position in VOR in Q1 2021 and has held it in 9 quarters since. The position peaked at $743K in Q2 2026. 47 funds tracked by Wall St. Rank hold VOR as of Q3 2026.

Deutsche Bank held 34,665 shares of Vor Biopharma worth $661K as of Q3 2026.
Deutsche Bank sold 5,686 Vor Biopharma shares in Q3 2026, an estimated $121K.
Vor Biopharma made up ﹤0.01% of Deutsche Bank's portfolio in Q3 2026, its #2475 holding.
Deutsche Bank first reported a position in Vor Biopharma in Q1 2021 and has held it in 9 quarters since.
Deutsche Bank's Vor Biopharma position peaked at $743K in Q2 2026.
47 funds tracked by Wall St. Rank held Vor Biopharma as of Q3 2026.

Based on Deutsche Bank's 13F filing for Q3 2026, filed 6 Nov 2026.